Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Globus Medical (GMED)
NYSE:GMED
Holding GMED?
Track your performance easily
GMED Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$43.39 - $74.21
Previous Close$69.59
Volume383.81K
Average Volume (3M)881.28K
Market Cap
$9.55B
Enterprise Value$9.87B
Total Cash (Recent Filing)$82.51M
Total Debt (Recent Filing)$529.30M
Price to Earnings (P/E)235.0
Beta1.13
Next Earnings
Nov 05, 2024EPS Estimate
$0.65Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.30
Shares Outstanding135,407,017
10 Day Avg. Volume476,006
30 Day Avg. Volume881,276
Standard Deviation0.10
R-Squared0.37
Alpha-0.00370
Financial Highlights & Ratios
Price to Book (P/B)2.37
Price to Sales (P/S)4.20
Price to Cash Flow (P/CF)43.30
P/FCF Ratio83.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.41
Enterprise Value/Gross Profit9.67
Enterprise Value/Ebitda22.90
Forecast
1Y Price Target
$79.33Price Target Upside12.48% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering15
Globus Medical News
PremiumPress Releases
Globus Medical Launches ADIRA™ XLIF™ Plate System
Bulls Say, Bears Say
Bulls Say
Financial PerformanceTotal sales were $630 million, representing a 116% year-over-year increase, and surpassed the Street's expectation of $615 million.
Operational SynergyGMED is confident in its integration efforts and expects to achieve $170 million in cost synergies with 40% in Year 1.
Product DevelopmentGMED continues to invest heavily in product development, having launched four products during Q2 2024, with expectations for record launches this year.
Bears Say
Market CompetitionTwo large players recently received FDA approval for their Spine robots, which adds competition for GMED.
Regulatory IssuesIf the company failed to address the FDA’s issues and there were repeat violations during another inspection, then the company would face potentially greater regulatory consequences.
Revenue ImpactThe robot will likely be soft launched at first and will most likely not contribute meaningfully to revenues in 2024.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
GMED FAQ
What was Globus Medical’s price range in the past 12 months?
Globus Medical lowest stock price was $43.38 and its highest was $74.21 in the past 12 months.
What is Globus Medical’s market cap?
Currently, no data Available
When is Globus Medical’s upcoming earnings report date?
Globus Medical’s upcoming earnings report date is Nov 05, 2024 which is in 46 days.
How were Globus Medical’s earnings last quarter?
Globus Medical released its earnings results on Aug 06, 2024. The company reported $0.75 earnings per share for the quarter, beating the consensus estimate of $0.677 by $0.073.
Is Globus Medical overvalued?
According to Wall Street analysts Globus Medical’s price is currently Undervalued.
Does Globus Medical pay dividends?
Globus Medical does not currently pay dividends.
What is Globus Medical’s EPS estimate?
Globus Medical’s EPS estimate is $0.65.
How many shares outstanding does Globus Medical have?
Globus Medical has 112,976,920 shares outstanding.
What happened to Globus Medical’s price movement after its last earnings report?
Globus Medical reported an EPS of $0.75 in its last earnings report, beating expectations of $0.677. Following the earnings report the stock price went up 2.143%.
Which hedge fund is a major shareholder of Globus Medical?
Among the largest hedge funds holding Globus Medical’s share is Fisher Asset Management LLC. It holds Globus Medical’s shares valued at 26M.
---
Globus Medical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$79.33 (12.48% Upside)
$79.33 (12.48% Upside)
Blogger Sentiment
Bullish
GMED Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 247.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $2.8M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 2.6%
Last 30 Days ▲ 3.6%
Last 30 Days ▲ 3.6%
Technicals
SMA
Positive
20 days / 200 days
Momentum
34.86%
12-Months-Change
Fundamentals
Return on Equity
1.36%
Trailing 12-Months
Asset Growth
125.71%
Trailing 12-Months
Company Description
Globus Medical
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.
---
GMED Earnings Call
Q2 2024
0:00 / 0:00
---
GMED Net sales Breakdown
92.34% Musculoskeletal Solutions
7.66% Enabling Technologies
---
GMED Stock 12 Month Forecast
Average Price Target
$79.33
▲(12.48% Upside)
Technical Analysis
Best Analysts Covering GMED
1 Year
1 Year Success Rate
21/28 ratings generated profit
1 Year Average Return
+17.18%
assigned a buy rating last month
Copying Matt Miksic's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +17.18% per trade.
---